About Novuson Surgical
Novuson Surgical is a Healthcare company based in Bothell (United States) founded in 2014. Ultrasound devices for tissue ablation and hemostatic control are provided. Novuson Surgical has raised $2.88 million across 5 funding rounds from investors including HOYA and HHS. The company has 3 employees. Novuson Surgical offers products and services including 3 MM Mini LS and 10 mm maxx. Its focus areas include Life Sciences, Surgical Instruments and Hemostats. Its legal entity is Novuson Surgical, Inc. Its competitors include Abyrx, Prytime Medical Devices and Endomedix; 3 of its 3 listed competitors have raised funding.
Company details
Novuson has developed a platform technology for ablating tissue, isolating tumors and providing hemostatic control during and before surgery. The technology consists of a control console, smart applicator handles and three applicator configurations - ultrasonic clamp, wide beam ablation cauterization probe and a precision beam scalpel. The company has received multiple grants from NIH. It has partnered with the Madigan Military Medical Center for human trials and plans to partner with Alliance Surgical for sales distribution.
- Headquarters Bothell, United States
- Employees 3
- SectorsHealthcare
- Website novuson.com
- Social LinkedIn
- Legal Name Novuson Surgical, Inc.
- Annual Revenue$9.43 K (USD)as on Dec 31, 2021
- Net Profit-$1.13 M (USD)-54as on Dec 31, 2021
- Total Equity Funding$2.88M (USD)
in 5 rounds
- Latest Funding Round$2.38M (USD), Series A
Mar 2020
- InvestorsHOYA
& 1 more
- Employee Count3
Products & Services of Novuson Surgical
Novuson Surgical offers a comprehensive portfolio of products and services, including 3 MM Mini LS and 10 mm maxx.
Device seals and divides vessels up to 7mm in minimally invasive surgery.
Tool provides hemostasis for thick tissues to improve surgical outcomes.
Funding Insights of Novuson Surgical
Novuson Surgical has successfully raised a total of $2.88M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.38 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.88M
- Total Rounds 5
- Last Round Series A — $2.38M
- First Round $1.47M
(Jul 2014)
- Investors Count 2
All 5 funding rounds of Novuson Surgical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Novuson Surgical
Novuson Surgical has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HOYA and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A wide range of medical devices is developed by HOYA. | 1941 | hoya.com | Tokyo, Japan | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Novuson Surgical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Novuson Surgical
3 dated milestones of Novuson Surgical across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Novuson Surgical is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series A, of $2.4M.
Competitors of Novuson Surgical
Novuson Surgical has 3 listed competitors in our database, 3 of them funded. They include Abyrx, Prytime Medical Devices and Endomedix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abyrx.com | 2013 | Irvington, United States | $10M | Hemostatic bone putty is developed for surgical bone bleeding control. | ||
| prytimemedical.com | 2011 | Boerne, United States | $10M | 41 | Developer of minimally invasive large vessel occludes for hemorrhage control in trauma patients | |
| endomedix.com | 2005 | Newark, United States | $1.99M | Hydrogel solutions for surgery and wound care are developed. |
Detailed competitors of Novuson Surgical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as Novuson Surgical (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 8.15 B | 6,357 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novuson Surgical
Complete news archive for Novuson Surgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novuson Surgical
Novuson Surgical was founded in 2014.
Novuson Surgical is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Novuson Surgical is a funded company, having raised a total of $2.88M across 5 funding rounds to date. The company's 1st funding round was a Grant of $1.47M, raised on Jul 2014.
Novuson Surgical has 3 employees.
Annual revenue of Novuson Surgical is $9.43K as on Dec 31, 2021.
Novuson has developed a platform technology for ablating tissue, isolating tumors and providing hemostatic control during and before surgery. The technology consists of a control console, smart applicator handles and three applicator configurations - ultrasonic clamp, wide beam ablation cauterization probe and a precision beam scalpel. The company has received multiple grants from NIH. It has partnered with the Madigan Military Medical Center for human trials and plans to partner with Alliance Surgical for sales distribution.
Novuson Surgical's top competitors include Prytime Medical Devices, Endomedix and Abyrx.
Novuson Surgical offers 3 MM Mini LS and 10 mm maxx.
Novuson Surgical operates through Novuson Surgical, Inc..